Prostate Cancer
#SUO14 - Session Highlights: What is the impact of ECOG 3805 (CHAARTED) results on clinical practice?
December 5, 2014
#SUO14 - Session Highlights: Non-genomic AR pathway
December 5, 2014
#SUO14 - Session Highlights: FSH and the metabolic syndrome
December 5, 2014
Safety and tolerability of DIM-based therapy designed as personalized approach to reverse prostatic intraepithelial neoplasia (PIN) - Abstract
December 5, 2014
End points of clinical trials in metastatic castration-resistant prostate cancer: A systematic review - Abstract
December 5, 2014
Particle radiotherapy for prostate cancer - Abstract
December 5, 2014
Is there any prognostic impact of intraductal carcinoma of prostate in initial diagnosed aggressively metastatic prostate cancer? - Abstract
December 5, 2014
Psychosocial adjustments in patients with prostate cancer from pre-diagnosis to 6 months post-treatment - Abstract
December 5, 2014
#SUO14 - Session Highlights: Targeting hormone-DNA repair crosstalk in prostate cancer: Implications for disease progression and therapeutic intervention
December 5, 2014
The association between nerve sparing and a positive surgical margin during radical prostatectomy - Abstract
December 5, 2014
Empiric antibiotics therapy for mildly elevated prostate specific antigen: Helpful to avoid unnecessary biopsies? - Abstract
December 4, 2014
#SUO14 - Session Highlights: Role of surgery for nodal oligometastatic disease in men with biochemical failure
December 4, 2014
#SUO14 - Session Highlights: Checkpoint targeted immunotherapy
December 4, 2014
#SUO14 - Session Highlights: Imaging for biochemical recurrence
December 4, 2014